The global antibodies market is projected to reach $524,782.9 million by 2030, exhibiting robust growth from $224,083.5 million in 2023, at an impressive CAGR of 12.9%. However, distinct from traditional drugs, biologics, including antibodies, necessitate Biologics License Applications (BLA) to be submitted to the Center for Biologics Evaluation and Research (CBER) for approval. Market DynamicsThe global antibodies market is characterized by increasing adoption of inorganic growth strategies among key players, including collaborations and partnerships, to expand their product portfolios. This trend is expected to drive market growth in the forecast period. Market SegmentationThe global antibodies market is segmented as follows:By Drug Type:Monoclonal Antibodies: Monoclonal antibody-based drugs.
